Concepedia

Author

Evangelos Terpos

National and Kapodistrian University of AthensORCID

Also Known As

Anderson, KC, E Terpos, E. TERPOS, E. Terpos, EVANGELOS TERPOS, Edward Stadtmauer, Evagelos Terpos, Evaggelos Terpos, Evangelia S. Makri, Evangelos Terpos

1.6K

Publications

53.3K

Citations

105

H-Index

237

Concepts

All Affiliations

National and Kapodistrian University of AthensAlexandra HospitalTheageneio General HospitalEvangelismos HospitalHellenic Air Force
ET

About

Evangelos Terpos is an author at National and Kapodistrian University of Athens specializing in medicine, hematology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

58

197

17.7K

2

Health Sciences

41

81

11.7K

3

Public Health

5

5

135

4

Engineering

4

4

81

5

Natural Sciences

2

2

56

Evangelos Terpos

×

411

Publications

31.1K

Citations

79

H-Index

YearCitations

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo,

The Lancet Oncology

2014

4.7K

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Aristotle Bamias, Efstathios Kastritis, Christina Bamia,

Journal of Clinical Oncology

2005

1.1K

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Philippe Moreau, Jesús F. San Miguel, Pieter Sonneveld,

Annals of Oncology

2017

847

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Meletios Α. Dimopoulos, Philippe Moreau, Evangelos Terpos,

Annals of Oncology

2021

782

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos,

Blood

2015

739

Bone health in cancer: ESMO Clinical Practice Guidelines

Robert E. Coleman, Peyman Hadji, Jean‐Jacques Body,

Annals of Oncology

2020

481

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

Meletios Α. Dimopoulos, Efstathios Kastritis, Christina Bamia,

Annals of Oncology

2008

437

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

Noopur Raje, Evangelos Terpos, Wolfgang Willenbacher,

The Lancet Oncology

2018

427

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis,

Blood

2009

425

Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

Evangelos Terpos, Richard Szydlo, Jane F. Apperley,

Blood

2003

410

Page 1